The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
New Perspectives on How to Discover Drugs from Herbal Medicines: CAM's Outstanding Contribution to Modern Therapeutics
Open accessAbstract
With tens of thousands of plant species on earth, we are endowed with an enormous wealth of medicinal remedies from Mother Nature. Natural products and their derivatives represent more than 50% of all the drugs in modern therapeutics. Because of the low success rate and huge capital investment need, the research and development of conventional drugs are very costly and difficult. Over the past few decades, researchers have focused on drug discovery from herbal medicines or botanical sources, an important group of complementary and alternative medicine (CAM) therapy. With a long history of herbal usage for the clinical management of a variety of diseases in indigenous cultures, the success rate of developing a new drug from herbal medicinal preparations should, in theory, be higher than that from chemical synthesis. While the endeavor for drug discovery from herbal medicines is “experience driven,” the search for a therapeutically useful synthetic drug, like “looking for a needle in a haystack,” is a daunting task. In this paper, we first illustrated various approaches of drug discovery from herbal medicines. Typical examples of successful drug discovery from botanical sources were given. In addition, problems in drug discovery from herbal medicines were described and possible solutions were proposed. The prospect of drug discovery from herbal medicines in the postgenomic era was made with the provision of future directions in this area of drug development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Natural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517 · cited 1×
“1% of a total of 155 clinically approved anticancer drugswere derived fromnature inNorthAmerica, Europe, and Japan market [27].”
BackgroundPlant Phenolics: Extraction, Analysis and Their Antioxidant and Anticancer Properties
Dai, J., & Mumper, R. J. (2010) · Molecules · doi:10.3390/molecules15107313 · Cited by 4,506
DrugBank: a comprehensive resource for in silico drug discovery and exploration
Wishart, D. S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj067 · Cited by 3,892
How many drug targets are there?
Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Production of the antimalarial drug precursor artemisinic acid in engineered yeast
Ro, D.-K., Paradise, E. M., Ouellet, M., Fisher, K. J., Newman, K. L., Ndungu, J. M., Ho, K. A., Eachus, R. A., Ham, T. S., Kirby, J., et al. (2006) · Nature · doi:10.1038/nature04640 · Cited by 2,805
Drug Discovery: A Historical Perspective
Drews, J. (2000) · Science · doi:10.1126/science.287.5460.1960 · Cited by 2,760
Medicinal plants: Traditions of yesterday and drugs of tomorrow
Gurib-Fakim, A. (2006) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2005.07.008 · Cited by 2,391
Cited by
Plant-Derived Natural Products: A Source for Drug Discovery and Development
Chaachouay, N., & Zidane, L. (2024) · Drugs and Drug Candidates · doi:10.3390/ddc3010011 · Cited by 1,081
Medicinal plants: Past history and future perspective
Jamshidi-Kia, F., Lorigooini, Z., & Amini-Khoei, H. (2018) · Journal of Herbmed Pharmacology · doi:10.15171/jhp.2018.01 · Cited by 925
Pan, S.-Y., Litscher, G., Gao, S.-H., Zhou, S.-F., Yu, Z.-L., Chen, H.-Q., Zhang, S.-F., Tang, M.-K., Sun, J.-N., & Ko, K.-M. (2014) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2014/525340 · Cited by 593
Self-citationSen, S., & Chakraborty, R. (2017) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2016.05.006 · Cited by 490
Saini, R. K., Sivanesan, I., & Keum, Y.-S. (2016) · 3 Biotech · doi:10.1007/s13205-016-0526-3 · Cited by 485
Validation of in-vitro bioassay methods: Application in herbal drug research
(2021) · Profiles of Drug Substances, Excipients and Related Methodology · doi:10.1016/bs.podrm.2020.07.005 · Cited by 482
Herbal Medicine for Cardiovascular Diseases: Efficacy, Mechanisms, and Safety
Shaito, A., Thuan, D. T. B., Phu, H. T., Nguyen, T. H. D., Hasan, H., Halabi, S., Abdelhady, S., Nasrallah, G. K., Eid, A. H., & Pintus, G. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00422 · Cited by 437
Role of plant alkaloids on human health: A review of biological activities
Debnath, B., Singh, W. S., Das, M., Goswami, S., Singh, M. K., Maiti, D., & Manna, K. (2018) · Materials Today Chemistry · doi:10.1016/j.mtchem.2018.05.001 · Cited by 384
Current pathogenic Escherichia coli foodborne outbreak cases and therapy development
Yang, S.-C., Lin, C.-H., Aljuffali, I. A., & Fang, J.-Y. (2017) · Archives of Microbiology · doi:10.1007/s00203-017-1393-y · Cited by 366
Abdallah, E. M., Alhatlani, B. Y., de Paula Menezes, R., & Martins, C. H. G. (2023) · Plants · doi:10.3390/plants12173077 · Cited by 327
Cell death mechanisms of plant-derived anticancer drugs: beyond apoptosis
Gali-Muhtasib, H., Hmadi, R., Kareh, M., Tohme, R., & Darwiche, N. (2015) · Apoptosis · doi:10.1007/s10495-015-1169-2 · Cited by 293
Integrated omics analysis of specialized metabolism in medicinal plants
Rai, A., Saito, K., & Yamazaki, M. (2017) · The Plant Journal · doi:10.1111/tpj.13485 · Cited by 290
Oxidative stress in alzheimer’s disease: A review on emergent natural polyphenolic therapeutics
Cassidy, L., Fernandez, F., Johnson, J. B., Naiker, M., Owoola, A. G., & Broszczak, D. A. (2020) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2019.102294 · Cited by 275
Lone, S. A., Khan, S., & Ahmad, A. (2020) · Archives of Microbiology · doi:10.1007/s00203-019-01781-2 · Cited by 32
Spirulina and Herbal Combination on Metabolic Alterations of Cardiovascular Diseases (CVDs)
Pandey, R., & Singh, S. (2022) · International Journal of Research and Review · doi:10.52403/ijrr.20220334 · Cited by 6
Metadata
- Authors
- Pan, S.-Y., Zhou, S.-F., Gao, S.-H., Yu, Z.-L., Zhang, S.-F., Tang, M.-K., Sun, J.-N., Ma, D.-L., Han, Y.-F., Fong, W.-F., & Ko, K.-M.
- Venue
- Evidence-Based Complementary and Alternative Medicine
- Publisher
- Wiley
- Published
- 2013
- Volume
- 2013
- Pages
- 1-25
- ISSN
- 1741-427X (ISSN-L)
- 1741-4288
- OpenAlex
- W2065380210
- Cited by
- 687
- References
- 147
- FWCI
- 21.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.